Corteva (NYSE:CTVA) underwent analysis by 12 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 6 | 1 | 0 | 0 |
| Last 30D | 1 | 0 | 0 | 0 | 0 |
| 1M Ago | 1 | 0 | 0 | 0 | 0 |
| 2M Ago | 1 | 4 | 1 | 0 | 0 |
| 3M Ago | 2 | 2 | 0 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $71.08, a high estimate of $74.00, and a low estimate of $64.00. This upward trend is apparent, with the current average reflecting a 3.15% increase from the previous average price target of $68.91.
A clear picture of Corteva's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Duffy Fischer | Goldman Sachs | Announces | Buy | $71.00 | - |
| Steve Byrne | B of A Securities | Raises | Buy | $73.00 | $69.00 |
| Arun Viswanathan | RBC Capital | Raises | Outperform | $73.00 | $72.00 |
| Kristen Owen | Oppenheimer | Raises | Outperform | $72.00 | $70.00 |
| Aleksey Yefremov | Keybanc | Raises | Overweight | $70.00 | $68.00 |
| Patrick Cunningham | Citigroup | Raises | Buy | $74.00 | $69.00 |
| Richard Garchitorena | Wells Fargo | Raises | Overweight | $73.00 | $67.00 |
| Benjamin Theurer | Barclays | Raises | Equal-Weight | $64.00 | $62.00 |
| Joshua Spector | UBS | Lowers | Buy | $73.00 | $74.00 |
| Aleksey Yefremov | Keybanc | Lowers | Overweight | $68.00 | $69.00 |
| Arun Viswanathan | RBC Capital | Raises | Outperform | $73.00 | $68.00 |
| Patrick Cunningham | Citigroup | Lowers | Buy | $69.00 | $70.00 |
For valuable insights into Corteva's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
Stay up to date on Corteva analyst ratings.
Corteva is an agricultural inputs pure play that was formed in 2019 when it was spun off from DowDuPont. The company is a leader in the development of new seed and crop protection products. Seeds generate the majority of profits with the remainder coming from crop protection products. Corteva operates globally, but around half of revenue comes from North America.
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Corteva's remarkable performance in 3 months is evident. As of 31 December, 2024, the company achieved an impressive revenue growth rate of 7.31%. This signifies a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Net Margin: Corteva's net margin excels beyond industry benchmarks, reaching -1.03%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Corteva's ROE excels beyond industry benchmarks, reaching -0.17%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of -0.1%, the company showcases effective utilization of assets.
Debt Management: Corteva's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.11.
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
March 14, 2025
·
Benzinga
Copyright © Traders & Quants
